1. Depth of Response and Early Tumor Shrinkage for Predicting Clinical Outcomes in HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab


    Yi-Qun Che et al, 2020, Cancer Management and Research CrossRef
  2. Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib
    Osman Ă–cal et al, 2022, Cancer Imaging CrossRef